| 1 |
Ziegler V, Henninger C, Simiantonakis I, et al. Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation[J]. Cell Death and Disease, 2017, 8(8): 978-979.
|
| 2 |
马晓梅，姬文莉，王翠翠，等. 新疆维吾尔族及汉族原发性肺癌临床病理特征分析[J]. 新疆医科大学学报，2014, 37(03): 325-327.
|
| 3 |
张永奎，谭林林，乐涵波，等. 原发性周围型小肺癌临床病理特征及预后分析[J]. 温州医科大学学报，2016, 46(06): 408-412.
|
| 4 |
吴光航，杨颖，任宏. 青年人非小细胞肺癌临床病理特征及预后分析[J]. 现代肿瘤医学，2015, 23(13): 1835-1837.
|
| 5 |
顾凤华，顾国建，练玲芝，等. 小细胞肺癌的临床病理特征及性别差异表现[J]. 实用癌症杂志，2015, 30(01): 93-95.
|
| 6 |
Kang CG, Im E, Lee H, et al. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice[J]. Bioorganic & Medicinal Chemistry Letters, 2017, 27(9): 1914-1918.
|
| 7 |
Ohata K, Chen-Yoshikawa TF, Menju T, et al. Protective Effect of Inhaled Rho-Kinase Inhibitor on Lung Ischemia-Reperfusion Injury[J]. The Annals of Thoracic Surgery, 2017, 103(2): 476-483.
|
| 8 |
曹勤琛，赵路军，王平. 非小细胞肺癌中EMT的发生机制及预后价值的研究进展[J]. 中国肺癌杂志，2014, 17(07): 569-574.
|
| 9 |
任卉，崔岩，吕秀云，等. 肺癌病人临床病理回顾性调查分析[J]. 内蒙古医科大学学报，2017, 39(01): 45-49.
|
| 10 |
钟立，孙彤，刘祖翠. ROCK在卵巢癌组织中的表达及其对卵巢癌细胞增殖与凋亡的影响[J]. 重庆医科大学学报，2014, 39(11): 1537-1541.
|
| 11 |
Ding R, Zhao D, Li X, et al. Rho-kinase inhibitor treatment prevents pulmonary inflammation and coagulation in lipopolysaccharide-induced lung injury[J]. Thrombosis Research, 2017, 150(06): 59-64.
|
| 12 |
Yu Q, Guo J, Chen Y, et al. Captopril pretreatment protects the lung against severe acute pancreatitis induced injury via inhibiting angiotensin II production and suppressing Rho/ROCK pathway[J]. The Kaohsiung Journal of Medical Sciences, 2016, 32(9): 439-445.
|
| 13 |
杨利凤，唐莲，黄蕾，等. Rho相关蛋白激酶及其抑制剂的研究进展[J]. 南通大学学报(医学版), 2016, 36(02): 148-152.
|
| 14 |
高英铭，辛华，程龙，等. rock 1蛋白在非小细胞肺癌中的表达[J]. 中国实验诊断学，2017, 21(3): 494-495.
|